Indications |
Oral Oedema Adult: 50-100 mg daily in 1-2 divided doses, may reduce to 25-50 mg on alternate days or intermittently. Max: 200 mg daily. Oral Hypertension Adult: Initial dose: 12.5 mg daily. Usual dose: 25-50 mg daily alone or in conjunction with other antihypertensives. Child: 1 mg/kg daily, may reduce dose for maintenance. |
Contraindications |
Severe hepatic or renal impairment; anuria; Addison's disease; hypercalcaemia. Pregnancy and lactation. |
Warnings / Precautions |
Fluid and electrolyte disturbances; hepatic cirrhosis; gout; DM. Elderly; severe heart failure; renal or hepatic impairment. Monitor blood glucose concentrations in patients taking antidiabetics. |
Adverse Reactions |
Electrolyte imbalance; hyperglycaemia; gout; dry mouth; thirst; weakness; muscle pain and cramp; seizures; hypotension; GI disturbances; anorexia; sialadenitis; headache; impotence; yellow vision; hypersensitivity reactions; cholestatic jaundice; pancreatitis; blood dyscrasias; glycosuria; dizziness; photosensitivity reactions, postural hypotension, paraesthesia. |
Overdose Reactions |
Lethargy, nausea, weakness and electrolyte imbalance, possibly progress to coma within a few hr with minimal depression of respiratory and CV function and with no evidence of dehydration or serum electrolyte changes. GI irritation and hypermotility, temporary elevation of the BUN, serum electrolyte changes (e.g. hypokalemia, hypochloremia, hyponatremia) may occur in renally impaired patients. Empty stomach by inducing vomiting with ipecac syrup If patient is conscious. Cathartics should not be admin as they may promote loss of fluid and electrolytes. Supportive and symptomatic treatment with monitoring of serum electrolytes, renal, respiratory, and CV function. Replace fluid and electrolytes where necessary. |
Drug Interactions |
Digitalis glycosides; drugs that prolong QT interval; other antihypertensives; competitive muscle relaxants; pressor amines; corticosteroids, corticotrophin; β2-agonists, α-blockers; ACE inhibitors; NSAIDs; alcohol, barbiturates; opioids; lithium; Allopurinol; tetracyclines; carbenoxolone; hypoglycaemics. See Below for More hydroflumethiazide Drug Interactions |
Mechanism of Actions |
Hydroflumethiazide reduces the reabsorption of electrolytes from the renal tubules, hence increasing the excretion of sodium and chloride ions and consequently of water. It also reduces the glomerular filtration rate. Onset: 2 hr. Duration: 24 hr. Absorption: Incompletely but fairly rapidly absorbed from the GI tract. Excretion: Excreted in the urine. |
ATC Classification |
C03AA02 - hydroflumethiazide ; Belongs to the class of low-ceiling thiazide diuretics. |
Available As |
|
Hydroflumethiazide
Post Review about Hydroflumethiazide Click here to cancel reply.
Hydroflumethiazide Containing Brands
Hydroflumethiazide is used in following diseases
Drug - Drug Interactions of Hydroflumethiazide
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.